Quercetin suppresses NF-κB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model

International Journal of Molecular Medicine

Volumn 30, Issue 1, 2012, Pages 119-125

  Chen, Pin ^a   Shi, Qiyang ^b   Xu, Xiangjin ^a   Wang, Yanqiao ^a   Chen, Wenyu ^a   Wang, Huiling ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chemoattractant protein 1; Diabetic nephropathy; Human mesangial cells; Nuclear factor B; Quercetin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; QUERCETIN;

ARTICLE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL2; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; INFLAMMATION; KIDNEY; MESANGIAL CELLS; NF-KAPPA B; PYRROLIDINES; QUERCETIN; SIGNAL TRANSDUCTION; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA;

EID: 84861468668     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.955     Document Type: Article

References (32)

1. Xiangjin X and Jiaqing Z: Inhibition of quercetin on non-enzymatic glycation and oxidation of diabetic rat kidneys. J Endocrinol Metabol 14: 34-37, 1998 (In Chinese).
2. Ruoslahti E, Yamaguchi Y, Hildebrand A and Border WA: Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol 57: 309-315, 1992.
3. Kamanna VS, Bassa BV and Ganji SH: Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation. Life Sci 83: 595-601, 2008.
4. Flavonoids: Chemistry, Biochemistry and Applications. Andersen OM, Markham KR (eds). CRC Press, Boca Raton, pp1-1256, 2006.
5. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP and Williams RL: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919, 2000.
6. Engelman JA, Luo J and Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619, 2006. (Pubitemid 44100518)
7. Foukas LC and Withers DJ: Phosphoinositide signalling pathways in metabolic regulation. Curr Top Microbiol Immunol 346: 115-141, 2010.
8. Cho SY, Park SJ, Kwon MJ, et al: Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243: 153-160, 2003.
9. Amalia PM, Possa MN, Augusto MC and Francisca LS: Quercetin prevents oxidative stress in cirrhotic rats. Dig Dis Sci 52: 2616-2621, 2007. (Pubitemid 47376649)
10. Hartge MM, Unger T and Kintscher U: The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 4: 84-88, 2007. (Pubitemid 47167491)
11. Coskun O, Kanter M, Korkmaz A and Oter S: Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 51: 117-123, 2005. (Pubitemid 40040541)
12. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K and Salimath PV: Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutr Res 24: 373-381, 2004. (Pubitemid 38739461)
13. Ramachandra R, Shetty AK and Salimath PV: Quercetin alleviates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res 49: 355-360, 2005. (Pubitemid 40545529)
14. Anjaneyulu M and Chopra K: Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31: 244-248, 2004. (Pubitemid 38507865)
15. Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM and Kim JL: Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 5: 107-111, 2011.
16. Moreira AJ, Fraga C, Alonso M, et al: Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol 68: 1939-1946, 2004. (Pubitemid 39346184)
17. Ha H and Lee HB: Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 10: S7-S10, 2005. (Pubitemid 41743468)
18. Yuan P, Xue H, Zhou L, et al: Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant 26: 2119-2126, 2011.
19. Danesh FR, Sadeghi MM, Amro N, et al: 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci USA 99: 8301-8305, 2002. (Pubitemid 34651047)
20. Gruden G, Perin PC and Camussi G: Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev 1: 27-40, 2005.
21. Sodhi CP, Phadke SA, Batlle D and Sahai A: Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280: F667-F674, 2001.
22. Mishra R, Emancipator SN, Kern T and Simonson MS: High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 67: 82-93, 2005. (Pubitemid 40019229)
23. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-(kappa)B activity. Annu Rev Immunol 18: 621-663, 2000. (Pubitemid 30365393)
24. Ha H, Cha MK, Choi HN and Lee HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22: 171-177, 2002. (Pubitemid 34546327)
25. Ihm CG, Park JK, Hong SP, et al: A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79: 33-37, 1998.
26. Min YD, Choi CH, Bark H, et al: Quercetin inhibits expression of infl ammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res 56: 210-215, 2007. (Pubitemid 46985839)
27. Retnamma Panickera S, Sreenivasb P, Sankar Babuc M, Karunagarand D and Cheranellore Kartha C: Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1. Pharmacol Res 62: 328-336, 2010.
28. Basta G, Schmidt AM and De Caterina R: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63: 582-592, 2004. (Pubitemid 39078671)
29. Kiyici S, Erturk E, Budak F, et al: Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy. Arch Med Res 37: 998-1003, 2006. (Pubitemid 44512061)
30. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y and Kasai K: Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58: 684-690, 2000. (Pubitemid 30620017)
31. Tashiro K, Koyanagi I, Saitoh A, et al: Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 16: 1-4, 2002.
32. Chacón MR, Fernández-Real JM, Richart C, et al: Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study. Obesity (Silver Spring) 15: 664-672, 2007. (Pubitemid 46643320)